Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 1.20B P/E 12.72 EPS this Y -29.80% Ern Qtrly Grth -42.90%
Income 55.3M Forward P/E 9.37 EPS next Y 5.20% 50D Avg Chg -11.00%
Sales 1.12B PEG - EPS past 5Y - 200D Avg Chg -25.00%
Dividend 2.00% Price/Book N/A EPS next 5Y - 52W High Chg -43.00%
Recommedations 3.50 Quick Ratio 1.55 Shares Outstanding 57.58M 52W Low Chg 8.00%
Insider Own 0.47% ROA 10.21% Shares Float 53.21M Beta 0.71
Inst Own 98.77% ROE - Shares Shorted/Prior 3.07M/3.10M Price 20.98
Gross Margin 66.55% Profit Margin 4.93% Avg. Volume 525,672 Target Price 16.50
Oper. Margin 25.93% Earnings Date May 10 Volume 565,107 Change -0.90%
About Embecta Corp.

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

EMBC Chatroom

User Image yay_buy_aap Posted - 6 days ago

$EMBC i buy more

User Image ParabolicVision Posted - 03/23/24

$EMBC What's wrong with this? Does it need a snickers? No, seriously... this chart looks sick but the company doesn't seem to be...

User Image yay_buy_aap Posted - 03/22/24

$EMBC Is there one person in the world who knows why it goes down?

User Image mark90 Posted - 4 weeks ago

$EMBC oversold

User Image Stock_Titan Posted - 1 month ago

$EMBC embecta-sponsored Educational Symposium and Abstracts at ATTD Highlight Role of Insulin Pumps in the Management of Type 2 Diabetes https://www.stocktitan.net/news/EMBC/embecta-sponsored-educational-symposium-and-abstracts-at-attd-ys8rvqaft541.html

User Image yay_buy_aap Posted - 1 month ago

$EMBC Why can't it go up????

User Image iruril Posted - 2 months ago

$EMBC I'm a buyer here. 100 shares incoming at market open

User Image insiderbuyingselling Posted - 2 months ago

$EMBC new insider buying: 2000 shares. http://insiderbuyingselling.com/?t=EMBC

User Image Newashi2024 Posted - 2 months ago

@Stocksrunner $EMBC Discount, I see great reversal tomorrow!

User Image Stocksrunner Posted - 2 months ago

πŸ“‰ Market Alert: Top Losers Today πŸ“‰πŸ’” $BIG: Big Lots faces a challenging outlook, plummeting 31% as Loop Capital downgrades to Sell. Analysts express grave concerns, projecting more downside. πŸ“‰ $EMBC: Embark registers oversold RSI, signaling potential reversal. Keep an eye on this one as the market dynamics unfold. πŸ”„ $OGI: Organigram Holdings braces for Q1 2024 earnings, navigating a challenging landscape. Investors tread cautiously. 🌐 Stay vigilant and adapt your strategy accordingly! πŸš¨πŸ“ˆ

User Image Fullratio Posted - 2 months ago

$EMBC ROA has plunged by 71% YoY and by 22% from the previous quarter: https://fullratio.com/stocks/nasdaq-embc/embecta

User Image Stocksrunner Posted - 2 months ago

πŸ“‰ Traders, keeping an eye on the market shakeup! πŸ”„ Today's top losers: 1️⃣ $EXPE - Plunges 13% post-2024 revenue warning on softening air fares. 2️⃣ $EMBC - Despite beating estimates, investors cautious after dividend announcement. 3️⃣ $PINS - Drops over 9% on weak Q1 revenue forecast. Stay informed, stay strategic! https://stocksrunner.com/home

User Image seviay Posted - 2 months ago

$EMBC reported earnings and revenue above consensus expectations and revised forward guidance upward...but it's down 15%. Now forward PE of ~7.5. Someone clue me in here

User Image DonCorleone77 Posted - 2 months ago

$EMBC Embecta raises FY24 adjusted EPS view to $1.95-$2.15 from $1.90-$2.10 FY24 consensus $2.00. Raises FY24 revenue view to $1.094B-$1.116B from $1.085B-$1.105B, consensus $1.1B.

User Image DonCorleone77 Posted - 2 months ago

$EMBC Embecta reports Q1 adjusted EPS 61c, consensus 45c Reports Q1 revenue $277.3M, consensus $264.91M. "Building on our performance during 2023, embecta delivered strong results for the first quarter of 2024," said Devdatt Kurdikar, CEO of embecta. "During the first quarter, I am pleased to report that we transitioned approximately sixty percent of our revenue to our own ERP system, shared service capability and distribution infrastructure, while delivering financial results that exceeded our expectations. Importantly, we also made progress on our strategic priorities, including the 510(k) filing of our open-loop patch pump with the FDA. Given our performance during the first quarter, coupled with our outlook for the remainder of the year, we are raising our guidance for certain key financial reporting metrics."

User Image Stock_Titan Posted - 2 months ago

$EMBC Embecta Corp. Reports First Quarter Fiscal 2024 Financial Results https://www.stocktitan.net/news/EMBC/embecta-corp-reports-first-quarter-fiscal-2024-financial-d7kyh9xvhwba.html

User Image Stock_Titan Posted - 2 months ago

$EMBC embecta Announces Quarterly Cash Dividend https://www.stocktitan.net/news/EMBC/embecta-announces-quarterly-cash-vpy25kg4syeb.html

User Image Stock_Titan Posted - 2 months ago

$EMBC embecta to Participate in the 11th Annual BTIG MedTech Conference https://www.stocktitan.net/news/EMBC/embecta-to-participate-in-the-11th-annual-btig-med-tech-aru5maxh0kyq.html

User Image David4W Posted - 2 months ago

$CVNA $WW $EMBC $EAF $REAL highly leverage businesses moving up north of 5% today

User Image digitalcori Posted - 2 months ago

πŸ’ΌπŸ’° Portfolio update: Tom Gayner from Markel Corp Q4 2023 πŸ“ˆ216 stocks, valued at $8.57 Billion. 🌐Top Buys: $SPY, $MAS, $EMBC, $FANG, and $FHB https://tickertracker.io/articles/v1e8dp08q2-tom-gayner-s-markel-corp-q4-2023-portfolio-revealed-a-deep-dive-into-the-8-57-billion-asset-distribution

User Image digitalcori Posted - 2 months ago

πŸš€πŸ“° Breaking: Yacktman Asset Management's Q4 Report is In! πŸ’‘πŸ“ŠDiscover the Companies Fueling a $10.1B Portfolio! #FinanceNews #StockMarket Top Buys: $SPY, $MAS, $EMBC, $FANG, and $FHB https://tickertracker.io/articles/pyo82d95v0-investor-watch-examining-donald-yacktman-s-q4-2023-portfolio

User Image cctranscripts Posted - 01/23/24

Statement of acquisition of beneficial ownership by individuals https://www.conferencecalltranscripts.org/summary/?id=12886672 $EMBC

User Image cctranscripts Posted - 01/22/24

Israel A. Englander just provided an update on share ownership of Embecta Corp. https://www.conferencecalltranscripts.org/summary/?id=12884286 $EMBC

User Image cctranscripts Posted - 01/22/24

BlackRock, Inc. just provided an update on share ownership of Embecta Corp. https://www.conferencecalltranscripts.org/summary/?id=12883523 $EMBC

User Image StockAutomatePro Posted - 3 months ago

$EMBC Stock headed for a drop chart shows. We alerted the SELL signal at $18.85 and we were able to close this one with profit at $16.78 βœ…

User Image StockAutomatePro Posted - 3 months ago

$EMBC Stock headed for a drop chart shows. We alerted the SELL signal at $18.93 and we were able to close this one with profit at $17.21 πŸ“Š

User Image StockAutomatePro Posted - 3 months ago

$EMBC Chart isn't looking promising for the stock. We alerted the SELL signal at $18.94 and we were able to close this one with profit at $17.25 😎

User Image DonCorleone77 Posted - 3 months ago

$EMBC Embecta announces FDA 510(k) submission for insulin patch pump Embecta announced that it has submitted a 510(k) premarket filing to the U.S. FDA for a proprietary disposable insulin delivery system.

User Image Stock_Titan Posted - 3 months ago

$EMBC embecta Announces FDA 510(k) Submission for Insulin Patch Pump https://www.stocktitan.net/news/EMBC/embecta-announces-fda-510-k-submission-for-insulin-patch-1vtr0lqnkpv6.html

Analyst Ratings
Morgan Stanley Underweight Nov 22, 23
Morgan Stanley Underweight Oct 18, 23
Morgan Stanley Underweight Aug 24, 23
Morgan Stanley Underweight Jul 18, 23
Morgan Stanley Underweight May 15, 23
Morgan Stanley Underweight Jan 6, 23
Morgan Stanley Equal-Weight Dec 21, 22
Morgan Stanley Equal-Weight Oct 11, 22
BTIG Neutral Sep 8, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Melcher David F Director Director Sep 08 Buy 15.7662 6,233 98,271 27,698 09/08/23
Kurdikar Devdatt President and CEO President and CEO Aug 10 Buy 21.81 5,000 109,050 244,791 08/10/23
Mann Jeffrey Z SVP, GC, Head Corp... SVP, GC, Head Corp. Dev., Secy Aug 10 Buy 21.67 4,700 101,849 55,333 08/10/23
Elguicze Jacob SVP and CFO SVP and CFO Aug 10 Buy 21.6637 4,625 100,195 66,027 08/10/23
Melcher David F Director Director Feb 15 Buy 32.51 3,100 100,781 21,465 02/15/23